Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CBAN Stock Summary
Top 10 Correlated ETFs
CBAN
In the News
CBAN Financial details
Company Rating
Buy
Market Cap
185.59M
Income
21.75M
Revenue
128.21M
Book val./share
14.51
Cash/share
24.63
Dividend
0.44
Dividend %
3.41%
Employees
453
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
10.44
Forward P/E
-
PEG
11.9
P/S
1.97
P/B
0.95
P/C
0.43
P/FCF
13.01
Quick Ratio
-
Current Ratio
-
Debt / Equity
0.94
LT Debt / Equity
0.66
-
-
EPS (TTM)
1.24
EPS next Y
-
EPS next Q
-
EPS this Y
8.77%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
2.06%
Revenue last 5Y
20.75%
Revenue Q/Q
44.89%
EPS Q/Q
-3.03%
-
-
-
-
SMA20
-
SMA50
-8.33%
SMA100
-
Inst Own
45.51%
Inst Trans
0.92%
ROA
1%
ROE
9%
ROC
0.01%
Gross Margin
100%
Oper. Margin
32%
Profit Margin
19%
Payout
27%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.59-13.58
52W High
-18.54%
52W Low
+32.38%
RSI
38
Rel Volume
0.16
Avg Volume
37.78K
Volume
5.94K
Perf Week
-0.38%
Perf Month
-4.68%
Perf Quarter
10.2%
Perf Half Y
5.37%
-
-
-
-
Beta
0.53
-
-
Volatility
0.06%, 0.26%
Prev Close
1.34%
Price
10.59
Change
0.67%
CBAN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.86 | 8.37 | 9.11 | 6.73 | 9.14 | |
Net income per share | 1.12 | 1.24 | 1.66 | 1.14 | 1.24 | |
Operating cash flow per share | 0.43 | -2.01 | 3.21 | 2.89 | 1.49 | |
Free cash flow per share | 0.05 | -2.46 | 2.69 | 2.73 | 1.28 | |
Cash per share | 49.27 | 59.41 | 101.76 | 26.36 | 24.62 | |
Book value per share | 14.29 | 15.21 | 19.34 | 13.39 | 14.5 | |
Tangible book value per share | 10.35 | 13.29 | 13.87 | 10.22 | 11.48 | |
Share holders equity per share | 14.29 | 15.21 | 19.34 | 13.39 | 14.5 | |
Interest debt per share | 11.36 | 7.74 | 8.72 | 19.46 | 14.23 | |
Market cap | 150.64M | 139.16M | 192.11M | 218.15M | 233.79M | |
Enterprise value | 133.92M | 15.94M | 83.32M | 400.92M | 448.73M | |
P/E ratio | 14.75 | 11.78 | 10.3 | 11.16 | 10.75 | |
Price to sales ratio | 2.41 | 1.75 | 1.87 | 1.89 | 1.45 | |
POCF ratio | 38.3 | -7.29 | 5.32 | 4.39 | 8.95 | |
PFCF ratio | 336.25 | -5.96 | 6.35 | 4.66 | 10.38 | |
P/B Ratio | 1.15 | 0.96 | 0.88 | 0.95 | 0.92 | |
PTB ratio | 1.15 | 0.96 | 0.88 | 0.95 | 0.92 | |
EV to sales | 2.14 | 0.2 | 0.81 | 3.47 | 2.79 | |
Enterprise value over EBITDA | 8.77 | 0.78 | 2.62 | 8.84 | -16.49 | |
EV to operating cash flow | 34.05 | -0.83 | 2.31 | 8.06 | 17.17 | |
EV to free cash flow | 298.92 | -0.68 | 2.75 | 8.56 | 19.93 | |
Earnings yield | 0.07 | 0.08 | 0.1 | 0.09 | 0.09 | |
Free cash flow yield | 0 | -0.17 | 0.16 | 0.21 | 0.1 | |
Debt to equity | 0.7 | 0.45 | 0.43 | 1.41 | 0.94 | |
Debt to assets | 0.06 | 0.04 | 0.03 | 0.11 | 0.08 | |
Net debt to EBITDA | -1.09 | -6.01 | -3.42 | 4.03 | -7.9 | |
Current ratio | 84.67 | 106.21 | 215.55 | 0.25 | 0.05 | |
Interest coverage | 1 | 1.86 | 5.27 | 3.1 | 2.46 | |
Income quality | 0.39 | -1.62 | 1.93 | 2.55 | 1.2 | |
Dividend Yield | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | |
Payout ratio | 0.26 | 0.32 | 0.24 | 0.37 | 0.36 | |
Sales general and administrative to revenue | 0.42 | 0.43 | 0.44 | 0.46 | 0.31 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.89 | 0.22 | -0.16 | -0.06 | -0.14 | |
Capex to revenue | -0.06 | -0.05 | -0.06 | -0.03 | -0.02 | |
Capex to depreciation | -1.31 | -0.72 | -0.68 | -0.25 | -0.93 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0.02 | 0.01 | |
Graham number | 18.97 | 20.63 | 26.86 | 18.51 | 20.09 | |
ROIC | 0.05 | 0.06 | 0.06 | 0.05 | 0.04 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | -102.41 | -111.08 | -118.07 | -131.07 | -134.76 | |
Working capital | 444.53M | 559.01M | 1.14B | -1.39B | -1.78B | |
Tangible asset value | 110.97M | 125.93M | 156.08M | 175.68M | 201.82M | |
Net current asset value | -934.96M | -1.06B | -1.33B | -2.25B | -2.7B | |
Invested capital | 0.7 | 0.45 | 0.43 | 1.41 | 0.94 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.08 | 0.08 | 0.09 | 0.08 | 0.09 | |
Capex per share | -0.38 | -0.45 | -0.52 | -0.17 | -0.21 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.65 | 1.6 | 1.6 | 1.67 | 2.42 | |
Net income per share | 0.31 | 0.29 | 0.3 | 0.33 | 0.32 | |
Operating cash flow per share | 0.81 | 0.65 | -0.27 | 0.49 | 0.28 | |
Free cash flow per share | 0.73 | 0.6 | -0.34 | 0.43 | 0.24 | |
Cash per share | 25.7 | 29.36 | 32.77 | 30.79 | 24.63 | |
Book value per share | 13.06 | 13.57 | 13.62 | 13.59 | 14.51 | |
Tangible book value per share | 9.96 | 154.26 | 160.91 | 158.91 | 11.49 | |
Share holders equity per share | 13.06 | 13.57 | 13.62 | 13.59 | 14.51 | |
Interest debt per share | 18.64 | 19.67 | 15.93 | 17.72 | 13.77 | |
Market cap | 223.74M | 179.48M | 165.61M | 175.52M | 233.65M | |
Enterprise value | 406.51M | 325.89M | 229.16M | 282.6M | 448.59M | |
P/E ratio | 10.08 | 8.9 | 7.81 | 7.56 | 10.43 | |
Price to sales ratio | 7.69 | 6.36 | 5.89 | 5.98 | 5.5 | |
POCF ratio | 15.67 | 15.76 | -35.07 | 20.54 | 48.17 | |
PFCF ratio | 17.44 | 17.1 | -28.06 | 22.99 | 55.41 | |
P/B Ratio | 0.97 | 0.75 | 0.69 | 0.74 | 0.92 | |
PTB ratio | 0.97 | 0.75 | 0.69 | 0.74 | 0.92 | |
EV to sales | 13.98 | 11.55 | 8.15 | 9.63 | 10.55 | |
Enterprise value over EBITDA | 29.78 | 23.34 | 35.25 | 37.89 | -63.25 | |
EV to operating cash flow | 28.47 | 28.62 | -48.53 | 33.07 | 92.47 | |
EV to free cash flow | 31.68 | 31.06 | -38.83 | 37.01 | 106.38 | |
Earnings yield | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | |
Free cash flow yield | 0.06 | 0.06 | -0.04 | 0.04 | 0.02 | |
Debt to equity | 1.41 | 1.42 | 1.12 | 1.25 | 0.94 | |
Debt to assets | 0.11 | 0.11 | 0.09 | 0.1 | 0.08 | |
Net debt to EBITDA | 13.39 | 10.48 | 9.78 | 14.36 | -30.31 | |
Current ratio | 0.25 | 0.8 | 0.34 | 0.42 | 0.05 | |
Interest coverage | 2.28 | 1.5 | 0.56 | 0.58 | 2.57 | |
Income quality | 2.57 | 2.26 | -0.89 | 1.47 | 0.87 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.34 | 0.38 | 0.36 | 0.33 | 0.34 | |
Sales general and administrative to revenue | 0.42 | 0.45 | 0.47 | 0.41 | 0.07 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.1 | -0.08 | 0.25 | -0.11 | -0.13 | |
Capex to revenue | -0.05 | -0.03 | -0.04 | -0.03 | -0.01 | |
Capex to depreciation | -0.63 | -0.4 | -0.52 | -0.43 | -0.31 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham number | 9.62 | 9.35 | 9.61 | 10.05 | 10.2 | |
ROIC | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | -127.8 | 16.38 | 20.35 | 16.65 | -134.84 | |
Working capital | -1.39B | -131.26M | -876.76M | -744.01M | -1.78B | |
Tangible asset value | 175.68M | 2.71B | 2.83B | 2.79B | 201.82M | |
Net current asset value | -2.25B | 288.3M | 229.67M | 292.47M | -2.7B | |
Invested capital | 1.41 | 1.42 | 1.12 | 1.25 | 0.94 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | -324.17M | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex per share | -0.08 | -0.05 | -0.07 | -0.05 | -0.04 |
CBAN Frequently Asked Questions
What is Colony Bankcorp, Inc. stock symbol ?
Colony Bankcorp, Inc. is a US stock , located in Fitzgerald of Ga and trading under the symbol CBAN
What is Colony Bankcorp, Inc. stock quote today ?
Colony Bankcorp, Inc. stock price is $10.59 today.
Is Colony Bankcorp, Inc. stock public?
Yes, Colony Bankcorp, Inc. is a publicly traded company.